Latest Options News

Austal Limited has finalized a Strategic Shipbuilding Agreement with the Commonwealth of Australia, positioning its subsidiary as the nation’s key Tier 2 naval shipbuilder. This long-term pact sets the stage for significant defence vessel construction in Western Australia.

TechGen Metals Ltd has announced a fully underwritten pro-rata non-renounceable entitlement issue to raise approximately $2.57 million, offering new shares at $0.018 each with free attaching options. The capital raise aims to accelerate exploration at key projects in Western Australia.

Pinnacle Minerals Ltd is set to raise an additional $440,000 through a third tranche placement, aiming to accelerate its exploration programs and pursue new opportunities. This move follows strong investor demand and awaits shareholder approval.

Race Oncology’s Phase 1b/2 trial of RC110 bisantrene for relapsed or refractory acute myeloid leukemia has demonstrated a 40% response rate, exceeding expectations and offering new hope for difficult-to-treat patients.

Western Gold Resources has locked in a $3 million secured loan facility to fund critical drilling at its Gold Duke Project, pushing the mine closer to production with minimal shareholder dilution.

HeraMED Limited has raised $1.98 million through a discounted share placement to fund its digital maternity care platform's commercial growth across the US, Australia, and Europe.

TG Metals Limited has raised $2.6 million through a placement to accelerate exploration and development at its Van Gold Uden deposit and Gold City prospect in Western Australia.

Havilah Resources has struck a binding deal with Heavy Rare Earths, granting earn-in rights to its Prospect Hill tin project with a $1.5 million exploration commitment over three years. The arrangement allows Havilah to focus on its copper assets while retaining significant upside exposure.

The Lederer Group has announced an off-market takeover offer for all stapled securities in the Elanor Commercial Property Fund at 70 cents each, representing a premium over recent trading prices. The bid comes amid governance concerns and a proposed overhaul of the fund’s management structure.

Adherium Limited has raised A$0.35 million through an institutional placement, supplementing its recent entitlement offer to strengthen its financial position and support growth initiatives.

Papyrus Australia Ltd has announced a $262,000 capital raise through a share placement and unlisted options, aiming to strengthen its working capital and research efforts.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.